Rotigotine CAS 99795 59 6 GMP DMF C19H25NOS Molecular Formula

Rotigotine CAS : 99795-59-6 GMP DMF

Name : Rotigotine

CAS No . : 99795-59-6

Chemical Name : (S)-6-[Propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol

Molecular Formula : C19H25NOS

Molecular Weight : 315.48

Description: Rotigotine is the active pharmaceutical ingredient (API) of branded drug Neupro. The developing history of Rotigotine is quite long. It was developed in 1985 by University of Groningen. Aderis Pharmaceuticals continued its development. A German company called Schwarz Pharma (now a subsidiary of UCB S.A.) got worldwide development and commercialization rights from Aderis in 1998. Rotigotine is used to treat Parkinson’s disease (PD) and restless legs syndrome (RLS). Rogitine is maybe also useful to treat depression. Rogotine (Neupro) was approved by EMEA in Europe in 2006 and by FDA in USA in 2007.

The drug might be protected by patents in some courtires or areas. We only sell it to non patent protected countries or areas. The sale to patent protection countries and areas is only for R & D purpose. The buyers should take all responsiblity of patent status in his countries or areas.

Competitive Advantage: Produced under cGMP conditions, support customers’ registrations.